论文信息 - Efﬁcacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials - 字舞流文

Efﬁcacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

D. Shrom | R. Burge | C. Griffiths | M. Gooderham | K. Papp | K. Reich | P. Foley | C. Leonardi | L. Guenther | S. Gerdes | Chen-Yen Lin | A. Leung | Laura Ferris | H. Elmaraghy | H. Crane | L. Ferris